Signalling via PDL1 on human CD4+ Treg cells has been shown to have an important role in inducing a regulatory phenotype in healthy individuals by reducing ERK phosphorylation—an effect which was attenuated in RA donors due to elevated basal phosphorylated ERK levels7. This evidence concerns the gene CD4 and rheumatoid arthritis.